
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
G
GEHC
GE HealthCare Technologies Inc.
$74.27
-2.84 (-3.68%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$74.27
Live market price
P/E (TTM)
16.29
EPS: $4.56
P/S (TTM)
1.64
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:56:36 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
10.0M
% of Float
2.2%
Days to Cover
2.4
Avg Daily Vol
4.2M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.96
Leverage ratio
ROE (TTM)
20.73%
Return on equity
Income Statement
Revenue
$20.63B
Cost of Revenue
$12.38B
Gross Profit
$8.25B
Operating Income
$2.76B
Net Income
$2.15B
EPS (Quarter)
$4.55
EPS (TTM)
--
Balance Sheet
Total Assets
$36.91B
Total Liabilities
$26.31B
Shareholders' Equity
$10.39B
Current Assets
$12.50B
Current Liabilities
$9.11B
Cash & Equivalents
--
Long-Term Debt
$10.00B
Cash Flow
Operating Cash Flow
$1.99B
Investing Cash Flow
$-1.05B
Financing Cash Flow
$617.00M
Free Cash Flow
$940.00M
Profitability Margins
Gross Margin
39.99%
Operating Margin
13.40%
Net Profit Margin
10.44%
ROA (TTM)
5.84%
ROE (TTM)
20.73%
Data source: Polygon.io
Last updated: 3/8/2026, 5:56:36 AM
Company Profile
Symbol
GEHC
Market Cap
$33.85B
IPO Date
Dec 15, 2022
CEO
--
Employees
54,000
Sector
--
Industry
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Country
United States
Exchange
--
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Read More